Premier Alternatives

Mend (Pharmaceuticals and Biotechnology)

New York, NY · Founded 2014 · Privately Held (backing)

Developer of clinical nutritional products designed to assist people in healing and living a quality life. Mend (Pharmaceuticals and Biotechnology) is based in New York, NY and was founded in 2014. Its last reported valuation was $115 million in Feb 2026. It has raised $36.2 million.

Last reported valuation
$115.0M
Oct 2026
Priced at
—
Total raised
$36.2M
Last round
—
How much has Mend (Pharmaceuticals and Biotechnology) raised?
$36.2Macross 0 recorded rounds
Free account
More of Mend (Pharmaceuticals and Biotechnology) with a free account
  • ·The complete investor list: 16 names
  • ·Watch Mend (Pharmaceuticals and Biotechnology): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Mend (Pharmaceuticals and Biotechnology) investors

16 investors are on record for Mend (Pharmaceuticals and Biotechnology), including Alumni Ventures, S2G Investments, iSelect Fund and The Pay It Forward Company. By type, the record holds 6 venture capital firms and 4 family offices.

For fundraisers
Raising for a company like Mend (Pharmaceuticals and Biotechnology)?

16 investors have backed Mend (Pharmaceuticals and Biotechnology).

See all 16 investors →

Frequently asked about Mend (Pharmaceuticals and Biotechnology)

How much has Mend (Pharmaceuticals and Biotechnology) raised?
Mend (Pharmaceuticals and Biotechnology) has raised $36.2M in total across 0 recorded funding rounds.